• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Invitae Corporation Common Stock (NY: NVTA )

    N/A UNCHANGED
    Last Price Updated: 7:00 PM EST, Feb 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Invitae Corporation Common Stock

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
    Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's... 
    Via Benzinga
    Softbank-Backed Cohesity To Acquire Veritas Data Security Unit For $3B: Report
    Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary of Carlyle Group. 
    Via Benzinga
    US Stocks Gain; Uber Posts Upbeat Sales
    U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock
    The New York Stock Exchange has announced that it will begin the process of delisting NVTA stock based on its "abnormally low" price. 
    Via InvestorPlace
    Why Is Agrify (AGFY) Stock Up 57% Today?
    Agrify stock is rising higher on Tuesday as investors in AGFY celebrate a new milestone for the company with a successful installation. 
    Via InvestorPlace
    Is Invitae Stock a Buy Now?
    Invitae shares have lost more than 80% over the past year and a half. 
    Via The Motley Fool
    Looking Into Invitae's Recent Short Interest
    Via Benzinga
    (NVTA) - Analyzing Invitae's Short Interest
    Via Benzinga
    NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy
    NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending. 
    Via InvestorPlace
    Topics Bankruptcy
    Exposures Financial Legal
    Why Is Invitae (NVTA) Stock Down 75% Today?
    Although genetic testing specialist Invitae forwarded a compelling idea, the lack of business substance ultimately cratered NVTA stock. 
    Via InvestorPlace
    SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
    Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures. 
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Invitae’s High-Stakes Financial Maneuvering: Dilution Might Not Be That Bad
    Invitae Corporation faces significant challenges in addressing its liquidity concerns. The firm is exploring multiple strategies to stabilize its financial and operational footing. 
    Via Talk Markets
    Earnings Preview: Invitae
    Via Benzinga
    Is Invitae Stock a Buy Now?
    Invitae shares have dropped more than 60% this year. 
    Via The Motley Fool
    Why Is Genetic Testing Invitae Stock Trading Higher Today?
    Friday, the FDA granted de novo approval for Invitae Corporation's (NYSE: 
    Via Benzinga
    Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
    The company must pay $57 million in damages, but that's far less than expected. 
    Via Investor's Business Daily
    Topics Intellectual Property
    Exposures Intellectual Property
    US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
    Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from  
    Via Benzinga
    Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts
    Invitae layoffs are a hot topic on Friday after the genetics company announced a 15% reduction of its workforce to reduce costs. 
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff
    Better Growth Stock: CRISPR Therapeutics vs. Invitae
    One of these stocks may be riskier than the other... 
    Via The Motley Fool
    Invitae (NVTA) Q3 2023 Earnings Call Transcript
    NVTA earnings call for the period ending September 30, 2023. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
    Via Benzinga
    3 Things About Invitae Every Smart Investor Knows
    The last two years have been tumultuous, and there are no calm waters in sight. 
    Via The Motley Fool
    3 Penny Stocks That Look Like Intriguing Bets for the Long-Term
    Set aside opinions on penny stocks because these three represent companies worth considering as long-term bets. 
    Via InvestorPlace
    Why Invitae Stock Popped Today
    Invitae just received a key marketing authorization from the FDA for a first-of-its-kind cancer test. 
    Via The Motley Fool
    Exposures Product Safety
    Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations. 
    Via Benzinga
    Gold Down 1%; ISM Manufacturing PMI Tops Estimates
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 40 points on Monday. The Dow traded down 0.60% to 33,306.79 while the NASDAQ rose 0.29% to 13,257.86. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Coinbase (COIN) Stock Pops 5% on Singapore License News
    Coinbase has announced a new license from Singapore's Monetary Authority and that news has shares of COIN stock on the rise Monday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Is Intelligent Bio Solutions (INBS) Stock Down 52% Today?
    Intelligent Bio Solutions stock is falling hard on Friday after the company announced details of a share offering for INBS. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.